Brottem John L. insider trades
Brottem John L. has filed 53 Form 4s with the SEC that we hold, for Outset Medical, Inc. (OM) (General Counsel) and Alamar Biosciences, Inc. (ALMR) (General Counsel). Across all of them we count 0 purchases worth $0 and 65 sales worth $3.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 7 sales ($87.2K). The largest single trade was a sale of 12,761 shares of Outset Medical, Inc. worth $259.6K, dated 2022-11-30. The first filing on our record is dated 2021-07-15 and the latest 2026-09-16.
Outset Medical, Inc. (OM)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-07-15 | S, sale reported on Form 4 | 3,500 | $153.4K | 2021-07-15 |
| 2021-08-16 | S, sale reported on Form 4 | 3,500 | $135.4K | 2021-08-16 |
| 2021-09-07 | S, sale reported on Form 4 | 1,445 | $72.2K | 2021-09-07 |
| 2021-09-15 | S, sale reported on Form 4 | 3,500 | $176.1K | 2021-09-16 |
| 2021-09-15 | S, sale reported on Form 4 | 1,445 | $72.9K | 2021-09-16 |
| 2021-10-15 | S, sale reported on Form 4 | 3,500 | $171.6K | 2021-10-19 |
| 2021-10-19 | S, sale reported on Form 4 | 1,445 | $72.2K | 2021-10-19 |
| 2021-11-15 | S, sale reported on Form 4 | 1,445 | $73.7K | 2021-11-16 |
| 2021-11-15 | S, sale reported on Form 4 | 3,500 | $180.4K | 2021-11-16 |
| 2021-12-01 | S, sale reported on Form 4 | 3,500 | $167.7K | 2021-12-02 |
| 2022-01-03 | S, sale reported on Form 4 | 2,500 | $117.6K | 2022-01-04 |
| 2022-01-18 | S, sale reported on Form 4 | 3,000 | $106.8K | 2022-01-19 |
| 2022-01-18 | S, sale reported on Form 4 | 7,002 | $249.3K | 2022-01-19 |
| 2022-02-15 | S, sale reported on Form 4 | 3,000 | $107.8K | 2022-02-17 |
| 2022-02-15 | S, sale reported on Form 4 | 7,002 | $251.5K | 2022-02-17 |
| 2022-03-01 | S, sale reported on Form 4 | 1,003 | $43.9K | 2022-03-02 |
| 2022-03-15 | S, sale reported on Form 4 | 5,586 | $215.6K | 2022-03-15 |
| 2022-03-15 | S, sale reported on Form 4 | 1,000 | $38.6K | 2022-03-15 |
| 2022-03-16 | S, sale reported on Form 4 | 1,392 | $55.4K | 2022-03-17 |
| 2022-03-17 | S, sale reported on Form 4 | 1,400 | $56.6K | 2022-03-17 |
| 2022-04-18 | S, sale reported on Form 4 | 1,000 | $43.2K | 2022-04-18 |
| 2022-04-18 | S, sale reported on Form 4 | 1,415 | $61.2K | 2022-04-18 |
| 2022-05-17 | S, sale reported on Form 4 | 349 | $9.2K | 2022-05-17 |
| 2022-08-16 | S, sale reported on Form 4 | 351 | $7.5K | 2022-08-16 |
| 2022-11-16 | S, sale reported on Form 4 | 352 | $6.8K | 2022-11-17 |
| 2022-11-18 | S, sale reported on Form 4 | 1,918 | $36.4K | 2022-11-21 |
| 2022-11-30 | S, sale reported on Form 4 | 12,761 | $259.6K | 2022-12-01 |
| 2023-01-27 | S, sale reported on Form 4 | 4,282 | $119.6K | 2023-01-30 |
| 2023-02-16 | S, sale reported on Form 4 | 3,532 | $85.5K | 2023-02-17 |
| 2023-02-16 | S, sale reported on Form 4 | 2,829 | $67.8K | 2023-02-17 |
| 2023-02-16 | S, sale reported on Form 4 | 2,265 | $54.3K | 2023-02-17 |
| 2023-02-16 | S, sale reported on Form 4 | 1,000 | $24.4K | 2023-02-16 |
| 2023-02-16 | S, sale reported on Form 4 | 358 | $8.7K | 2023-02-16 |
| 2023-03-20 | S, sale reported on Form 4 | 1,415 | $29.5K | 2023-03-21 |
| 2023-03-20 | S, sale reported on Form 4 | 2,715 | $56.5K | 2023-03-21 |
| 2023-05-03 | S, sale reported on Form 4 | 1,414 | $28.3K | 2023-05-05 |
| 2023-05-16 | S, sale reported on Form 4 | 1,335 | $26.6K | 2023-05-17 |
| 2023-05-17 | S, sale reported on Form 4 | 1,317 | $26.4K | 2023-05-17 |
| 2023-05-17 | S, sale reported on Form 4 | 1,415 | $28.4K | 2023-05-17 |
| 2023-06-20 | S, sale reported on Form 4 | 1,414 | $31.1K | 2023-06-21 |
| 2023-07-19 | S, sale reported on Form 4 | 1,415 | $28.3K | 2023-07-20 |
| 2023-08-16 | S, sale reported on Form 4 | 1,364 | $20.6K | 2023-08-17 |
| 2023-11-16 | S, sale reported on Form 4 | 1,431 | $6.8K | 2023-11-17 |
| 2024-01-08 | S, sale reported on Form 4 | 7,344 | $40.3K | 2024-01-08 |
| 2024-01-16 | S, sale reported on Form 4 | 1,480 | $6.3K | 2024-01-17 |
| 2024-02-15 | S, sale reported on Form 4 | 3,341 | $11.9K | 2024-02-16 |
| 2024-05-16 | S, sale reported on Form 4 | 2,972 | $10.5K | 2024-05-17 |
| 2024-06-12 | S, sale reported on Form 4 | 10,569 | $50.5K | 2024-06-14 |
| 2024-08-15 | S, sale reported on Form 4 | 3,011 | $2.5K | 2024-08-15 |
| 2024-11-15 | S, sale reported on Form 4 | 3,203 | $2.6K | 2024-11-18 |
| 2025-01-07 | S, sale reported on Form 4 | 1,572 | $2.0K | 2025-01-07 |
| 2025-01-13 | S, sale reported on Form 4 | 20,492 | $16.6K | 2025-01-13 |
| 2025-01-21 | S, sale reported on Form 4 | 29,474 | $23.6K | 2025-01-22 |
| 2025-01-21 | S, sale reported on Form 4 | 2,679 | $2.1K | 2025-01-22 |
| 2025-01-21 | S, sale reported on Form 4 | 777 | $622 | 2025-01-22 |
| 2025-02-18 | S, sale reported on Form 4 | 6,145 | $5.5K | 2025-02-19 |
| 2025-05-15 | S, sale reported on Form 4 | 396 | $7.1K | 2025-05-16 |
| 2025-08-15 | S, sale reported on Form 4 | 383 | $4.9K | 2025-08-18 |
| 2025-11-17 | S, sale reported on Form 4 | 388 | $1.8K | 2025-11-18 |
| 2026-01-07 | S, sale reported on Form 4 | 224 | $956 | 2026-01-08 |
| 2026-01-20 | S, sale reported on Form 4 | 9,314 | $47.7K | 2026-01-21 |
| 2026-01-21 | S, sale reported on Form 4 | 1,180 | $5.9K | 2026-01-21 |
| 2026-02-17 | S, sale reported on Form 4 | 2,842 | $9.5K | 2026-02-19 |
| 2026-05-15 | S, sale reported on Form 4 | 2,638 | $9.8K | 2026-05-19 |
| 2026-08-17 | S, sale reported on Form 4 | 2,632 | $11.6K | 2026-08-18 |
Alamar Biosciences, Inc. (ALMR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1823381) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms